Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate The Oncology Institute, Inc. before investing.

In this article, we go over a few key elements for understanding The Oncology Institute, Inc.’s stock price such as:

• The Oncology Institute, Inc.’s current stock price and volume
• Why The Oncology Institute, Inc.’s stock price changed recently
• Upgrades and downgrades for TOI from analysts
• TOI’s stock price momentum as measured by its relative strength

About The Oncology Institute, Inc. (TOI)

Before we jump into The Oncology Institute, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Want to learn more about The Oncology Institute, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about The Oncology Institute, Inc..

The Oncology Institute, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, The Oncology Institute, Inc.’s stock price was $4.860.

The Oncology Institute, Inc. is down 4.14% from its previous closing price of $5.070.

During the last market session, The Oncology Institute, Inc.’s stock traded between $4.860 and $5.250. Currently, there are approximately 101.80 million shares outstanding for The Oncology Institute, Inc..

The Oncology Institute, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

The Oncology Institute, Inc. Stock Price History

The Oncology Institute, Inc.’s (TOI) price is currently down 10.5% so far this month.

During the month of July, The Oncology Institute, Inc.’s stock price has reached a high of $6.670 and a low of $4.700.

Over the last year, The Oncology Institute, Inc. has hit prices as high as $6.670 and as low as $2.320. Year to date, The Oncology Institute, Inc.’s stock is up 36.52%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused The Oncology Institute, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were analysts who downgraded The Oncology Institute, Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate The Oncology Institute, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on The Oncology Institute, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about The Oncology Institute, Inc. (TOI) by visiting AAII Stock Evaluator.

Relative Price Strength of The Oncology Institute, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, The Oncology Institute, Inc. has a weighted four-quarter relative price strength of 10.01%, which translates to a Momentum Score of 82 and is considered to be Very Strong.

Want to learn more about how The Oncology Institute, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

The Oncology Institute, Inc. Stock Price: Bottom Line

As of July 31, 2026, The Oncology Institute, Inc.’s stock price is $4.860, which is down 4.14% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like The Oncology Institute, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.